2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Primary Immune Thrombocytopenia: new trials by email Literature Review of Primary Immune Thrombocytopenia trials Research Report on Primary Immune Thrombocytopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients 2.5mg/d Hetrombopag - Primary Immune Thrombocytopenia | Phase 4 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 69 | 2022-05-01 | 2022-04-05 |
| Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) rhTPO, eltrombopag - Primary Immune Thrombocytopenia | Phase 4 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 96 | 2019-01-16 | 2019-11-15 |
Purpura, Thrombocytopenic, Idiopathic (2)
Autoimmune Diseases (2) · Blood Coagulation Disorders (2) · Blood Platelet Disorders (2) · Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhage (2) · Hemorrhagic Disorders (2) · Immune System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Purpura (2) · Purpura, Thrombocytopenic (2) · Signs and Symptoms (2) · Skin Manifestations (2)
eltrombopag (1) · hetrombopag (1)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2)
China (1)
Heng Mei, PhD (1) · Hu Yu, M.D., Ph.D (1)
PMID 15661401, PMID 19005182, PMID 19446149, PMID 22054810, PMID 22409309, PMID 2279341, PMID 23556122, PMID 34528239